Novel Drug Developed for Treatment of Insomnia, Drug for Treating Swimmer’s Ear Receives FDA Approval, Advanced Drug for Chronic Weight Management Developed - Drug Discovery Technology

USD 950

* Required Fields

USD 950

PAY BY INVOICE

Be the first to review this product

This issue profiles a novel drug developed for treatment of insomnia, a drug for treating swimmer’s ear receives that FDA approval, and development of an advanced drug for chronic weight management.

Table of Contents

Drug Discovery Technology Alert. Novel Drug Developed for Treatment of Insomnia; Drug for Treating Swimmer’s Ear Receives FDA Approval; Advanced Drug for Chronic Weight Management DevelopedIn This Issue1. DRUG FOR TREATING SWIMMER’S EAR RECEIVES FDA APPROVAL2. TREATMENT PROCEDURE TO TACKLE BACTERIAL VAGINOSIS3. ADVANCED DRUG FOR CHRONIC WEIGHT MANAGEMENT DEVELOPED4. NOVEL DRUG DEVELOPED FOR TREATMENT OF INSOMNIA5. DRUG TREATMENT FOR ORTHOSTATIC HYPOTENSION GETS CONDITIONAL APPROVAL FROM THE US FDA6. NOVEL SKIN TREATMENT FOR INFLAMMATORY BUMPS AND LESIONS DUE TO ROSACEA7. DRUG TREATMENT FOR COMPLICATED URINARY TRACT INFECTIONS RECEIVES FDA APPROVAL8. GLOBAL PATENTS ON THE TREATMENT OF ANGIOEDEMA




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 31-Oct-17

Region : Global

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Related Subscription

• One-2-One Analyst briefing call •
• Access to published and new research deliverables •
• Mid year service review •
• Virtual Analyst briefing •
• GIL conference seats •

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.